Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma [NA]

View source ↗

Summary

A clinical trial update describes using molecular profiling to tailor treatments for patients with high-grade glioma, aiming to improve individualized therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Glioma, Glioma of Brain | NA | Status: ACTIVE_NOT_RECRUITING